Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease

References

1. 1.↵
   1. Ashburner J,
   2. Friston KJ

   . Voxel-based morphometry: the methods. Neuroimage 2000; 11: 805–21

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hirata Y,
   2. Matsuda H,
   3. Nemoto K,
   4. et al

   . Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005; 382: 269–74

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Landgrebe M,
   2. Binder H,
   3. Koller M,
   4. et al

   . Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus. BMC Psychiatry 2008; 8: 23

   CrossRefPubMed
4. 4.↵
   1. Teipel SJ,
   2. Meindl T,
   3. Grinberg L,
   4. et al

   . Novel MRI techniques in the assessment of dementia. Eur J Nucl Med Mol Imaging 2008; 3 (suppl 1): S58–S69
5. 5.↵
   1. Shoulson I,
   2. Fahn S

   . Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1–3

   CrossRef
6. 6.↵
   Unified Huntington's Disease Rating Scale: reliability and consistency—Huntington Study Group. Mov Disord 1996; 11: 136–42

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Henley SM,
   2. Wild EJ,
   3. Hobbs NZ,
   4. et al

   . Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia 2008; 46: 2152–60. Epub 2008 Mar 6

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Henley SM,
   2. Wild EJ,
   3. Hobbs NZ,
   4. et al

   . Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol 2009; 256: 203–12. Epub 2009 Mar 5

   CrossRefPubMed
9. 9.↵
   1. Ashburner J

   . A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95–113. Epub 2007 Jul 18

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Genovese CR,
    2. Lazar NA,
    3. Nichols T

    . Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870–78

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Good CD,
    2. Johnsrude IS,
    3. Ashburner J,
    4. et al

    . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21–36

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Acer N,
    2. Sahin B,
    3. Bas O,
    4. et al

    . Comparison of three methods for the estimation of total intracranial volume: stereologic, planimetric, and anthropometric approaches. Ann Plast Surg 2007; 58: 48–53

    CrossRefPubMed
13. 13.↵
    1. Good CD,
    2. Johnsrude I,
    3. Ashburner J,
    4. et al

    . Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001; 14: 685–700

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Whitwell JL,
    2. Crum WR,
    3. Watt HC,
    4. et al

    . Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001; 22: 1483–89

    Abstract/FREE Full Text
15. 15.↵
    1. Kassubek J,
    2. Bernhard LG,
    3. Ecker D,
    4. et al

    . Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport 2004; 15: 363–65

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Paulsen JS,
    2. Magnotta VA,
    3. Mikos AE,
    4. et al

    . Brain structure in preclinical Huntington's disease. Biol Psychiatry 2006; 59: 57–63

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Scahill RI,
    2. Frost C,
    3. Jenkins R,
    4. et al

    . A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989–94

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kassubek J,
    2. Juengling FD,
    3. Kioschies T,
    4. et al

    . Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213–20

    Abstract/FREE Full Text
19. 19.↵
    1. Wilke M,
    2. Holland SK,
    3. Altaye M,
    4. et al

    . Template-O-Matic: a toolbox for creating customized pediatric templates. Neuroimage 2008; 41: 903–13. Epub 2008 Mar 8

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Poldrack RA,
    2. Fletcher PC,
    3. Henson RN,
    4. et al

    . Guidelines for reporting an fMRI study. Neuroimage 2007; 40: 409–14

    PubMed
21. 21.↵
    1. Ridgway GR,
    2. Henley SM,
    3. Rohrer JD,
    4. et al

    . Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008; 40: 1429–35

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Keller SS,
    2. Wilke M,
    3. Wieshmann UC,
    4. et al

    . Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004; 23: 860–68

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Reimold M,
    2. Slifstein M,
    3. Heinz A,
    4. et al

    . Effect of spatial smoothing on t-maps: arguments for going back from t-maps to masked contrast images. J Cereb Blood Flow Metab 2006; 26: 751–59

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Mechelli A,
    2. Price CJ,
    3. Friston KJ,
    4. et al

    . Voxel-based morphometry of the human brain: methods and applications. Current Medical Imaging Reviews 2005; 1: 105–113

    CrossRefWeb of Science
25. 25.↵
    1. Mühlau M,
    2. Weindl A,
    3. Wohlschlager AM,
    4. et al

    . Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm 2007; 114: 367–72

    CrossRefPubMedWeb of Science
26. 26.
    1. Peinemann A,
    2. Schuller S,
    3. Pohl C,
    4. et al

    . Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 2005; 239: 11–19

    CrossRefPubMedWeb of Science
27. 27.
    1. Barrios FA,
    2. Gonzalez L,
    3. Favila R,
    4. et al

    . Olfaction and neurodegeneration in HD. Neuroreport 2007; 18: 73–76

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Fan Y,
    2. Resnick SM,
    3. Wu X,
    4. et al

    . Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 2008; 41: 277–85

    CrossRefPubMed
29. 29.↵
    1. McClure RK,
    2. Phillips I,
    3. Jazayerli R,
    4. et al

    . Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res 2006; 148: 121–32

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Feigin A,
    2. Ghilardi MF,
    3. Huang C,
    4. et al

    . Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 2006; 59: 53–59

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Langbehn DR,
    2. Brinkman RR,
    3. Falush D,
    4. et al

    . A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267–77

    CrossRefPubMedWeb of Science
32. 32.
    1. Thieben MJ,
    2. Duggins AJ,
    3. Good CD,
    4. et al

    . The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815–28

    Abstract/FREE Full Text
33. 33.
    1. Ho AK,
    2. Nestor PJ,
    3. Williams GB,
    4. et al

    . Pseudo-neglect in Huntington's disease correlates with decreased angular gyrus density. Neuroreport 2004; 15: 1061–64

    CrossRefPubMedWeb of Science
34. 34.
    1. Kassubek J,
    2. Juengling FD,
    3. Ecker D,
    4. et al

    . Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005; 15: 846–53

    Abstract/FREE Full Text
35. 35.
    1. Douaud G,
    2. Gaura V,
    3. Ribeiro MJ,
    4. et al

    . Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562–75

    CrossRefPubMedWeb of Science
36. 36.
    1. Gavazzi C,
    2. Nave RD,
    3. Petralli R,
    4. et al

    . Combining functional and structural brain magnetic resonance imaging in Huntington disease. J Comput Assist Tomogr 2007; 31: 574–80

    CrossRefPubMedWeb of Science
37. 37.
    1. Jech R,
    2. Klempir J,
    3. Vymazal J,
    4. et al

    . Variation of selective gray and white matter atrophy in Huntington's disease. Mov Disord 2007; 22: 1783–89

    CrossRefPubMed
38. 38.
    1. Kipps CM,
    2. Duggins AJ,
    3. McCusker EA,
    4. et al

    . Disgust and happiness recognition correlate with anteroventral insula and amygdala volume respectively in preclinical Huntington's disease. J Cogn Neurosci 2007; 19: 1206–17

    CrossRefPubMedWeb of Science
39. 39.
    1. Mühlau M,
    2. Gaser C,
    3. Wohlschlager AM,
    4. et al

    . Striatal gray matter loss in Huntington's disease is leftward biased. Mov Disord 2007; 22: 1169–73

    CrossRefPubMedWeb of Science
40. 40.
    1. Ruocco HH,
    2. Bonilha L,
    3. Li LM,
    4. et al

    . Longitudinal analysis of regional gray matter loss in Huntington disease: effects of the length of the CAG repeat. J Neurol Neurosurg Psychiatry 2007; 79: 130–35

    CrossRefPubMed
41. 41.
    1. Wolf RC,
    2. Vasic N,
    3. Schonfeldt-Lecuona C,
    4. et al

    . Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007; 130: 2845–57

    Abstract/FREE Full Text
42. 42.
    1. Wolf RC,
    2. Vasic N,
    3. Schonfeldt-Lecuona C,
    4. et al

    . Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 2009; 30: 327–39

    CrossRefPubMedWeb of Science